Personalized CRT - MPP Post Approval Study

NCT ID: NCT03232944

Last Updated: 2021-02-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1338 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-07-05

Study Completion Date

2021-01-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this Post-Approval Study (PAS) is to evaluate the effectiveness of MPP to improve CRT response in the non-responder patient population when used in "real-world" clinical practice, following commercial release. This evaluation is based on the Clinical Composite Score which summarizes the proportions and frequencies of CRT non-responder patients who are "improved", "unchanged" or "worsened" after receiving MPP therapy. Patients will be followed for the duration of the PAS. This study is required by FDA as a condition of approval of the MPP feature and is integrated within the Product Surveillance Registry (PSR).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Medtronic market-released cardiac resynchronization therapy (CRT) Quadripolar (Quad) systems approved for commercial release with the Multiple Point Pacing (MPP) feature were eligible to contribute to the Post-Approval Study (PAS) objectives. Products with MPP capabilities receiving appropriate license or regulatory approval during the conduct of the PAS were included and contributed to the PAS objectives upon commercial release. CRT is an established pacing therapy for patients with heart failure (HF). CRT provides atrial- synchronized biventricular (BiV) pacing using standard pacing technology combined with a special third lead that is implanted via the coronary sinus and positioned in a cardiac vein to sense and/or pace the left ventricle (LV). Following a sensed atrial contraction or atrial paced event, both ventricles are stimulated to synchronize their contraction. The MPP feature is designed to allow a second LV pace to occur in LV Only or BiV pace configurations. In the LV Only pace configuration, the LV paces occur simultaneously or sequentially (LV- LV), as applicable by product. When Bi-V pacing is enabled, the RV pace can be delivered either before or after the LV paces, with the order determined by the programmed Ventricular Pacing Configuration.

The MPP PAS was a global, prospective, observational multi-center study. Patients implanted with an eligible CRT Quad system were enrolled and followed in the Product Surveillance Registry per the expected standard of care practices of their care provider.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CRT non-responders with MPP enabled

Patients enrolled and implanted with a CRT Quad system, who are identified as CRT non-responder, for which MPP is enabled.

Cardiac Resynchronization Therapy - MPP

Intervention Type DEVICE

The multiple point pacing feature (MPP) is designed to allow pacing from 2 LV electrodes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cardiac Resynchronization Therapy - MPP

The multiple point pacing feature (MPP) is designed to allow pacing from 2 LV electrodes.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
* Patient has or is intended to receive or be treated with an eligible CRT device
* Patient within 30 days of therapy received at the time of their initial PSR platform enrollment

Exclusion Criteria

* Patient who is, or is expected to be inaccessible for follow-up
* Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medtronic

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alabama at Birmingham

Birmingham, Alabama, United States

Site Status

Saint Vincent Heart Clinic Arkansas

Little Rock, Arkansas, United States

Site Status

Chula Vista Cardiac Center

Chula Vista, California, United States

Site Status

Desert Heart Rhythm Consultants

Palm Springs, California, United States

Site Status

COR Healthcare

Torrance, California, United States

Site Status

Colorado Springs Cardiology

Colorado Springs, Colorado, United States

Site Status

Denver Heart

Denver, Colorado, United States

Site Status

Colorado Heart and Vascular, PC

Lakewood, Colorado, United States

Site Status

Heart Rhythm Solutions

Hollywood, Florida, United States

Site Status

Baptist Health

Jacksonville, Florida, United States

Site Status

Heart & Vascular Institute of Florida

Safety Harbor, Florida, United States

Site Status

Phoebe Putney Memorial Hospital

Albany, Georgia, United States

Site Status

The University of Kansas Medical Center

Kansas City, Kansas, United States

Site Status

MedStar Health Research Institute

Baltimore, Maryland, United States

Site Status

The Johns Hopkins Hospital

Bethesda, Maryland, United States

Site Status

Delmarva Heart Research Foundation Inc

Salisbury, Maryland, United States

Site Status

Massachusetts General Hospital

Boston, Massachusetts, United States

Site Status

Brigham and Women's Hospital

Boston, Massachusetts, United States

Site Status

UP Health System - Marquette

Marquette, Michigan, United States

Site Status

Michigan Heart

Ypsilanti, Michigan, United States

Site Status

Minneapolis Heart Institute Foundation

Minneapolis, Minnesota, United States

Site Status

North Memorial Heart and Vascular Institute

Robbinsdale, Minnesota, United States

Site Status

Mayo Clinic

Rochester, Minnesota, United States

Site Status

Missouri Cardiovascular Specialists

Columbia, Missouri, United States

Site Status

Washington University School of Medicine

St Louis, Missouri, United States

Site Status

HealthCare Partners Medical Group

Henderson, Nevada, United States

Site Status

Presbyterian Heart Group

Albuquerque, New Mexico, United States

Site Status

Island Cardiac Specialists

Garden City, New York, United States

Site Status

Huntington Hospital

Huntington, New York, United States

Site Status

Northwell Health

Manhasset, New York, United States

Site Status

Hudson Valley Heart Center

Poughkeepsie, New York, United States

Site Status

Central New York Cardiology

Utica, New York, United States

Site Status

WakeMed Health & Hospitals

Raleigh, North Carolina, United States

Site Status

Northeast Ohio Cardiovascular Specialists

Akron, Ohio, United States

Site Status

The Christ Hospital Health Network

Cincinnati, Ohio, United States

Site Status

University of Cincinnati

Cincinnati, Ohio, United States

Site Status

Mercy Health - Saint Vincent Medical Center

Toledo, Ohio, United States

Site Status

Cleveland Clinic

Cleveland, Oklahoma, United States

Site Status

Lehigh Valley Health Network

Allentown, Pennsylvania, United States

Site Status

Geisinger Medical Center

Danville, Pennsylvania, United States

Site Status

Geisinger Wyoming Valley Medical Center

Wilkes-Barre, Pennsylvania, United States

Site Status

Saint Thomas Research Institute

Nashville, Tennessee, United States

Site Status

Texas Cardiac Arrhythmia Research Foundation

Austin, Texas, United States

Site Status

The University of Vermont Medical Center

Burlington, Vermont, United States

Site Status

Kootenai Heart Clinics Northwest

Spokane, Washington, United States

Site Status

Aurora Cardiovascular Services

Milwaukee, Wisconsin, United States

Site Status

UZ Leuven - Campus Gasthuisberg

Leuven, , Belgium

Site Status

CHU UCL Mont-Godinne - Dinant

Yvoir, , Belgium

Site Status

Montreal Heart Institute

Montreal, Quebec, Canada

Site Status

Institut de cardiologie et de pneumologie de Québec (IUCPQ)

Québec, Quebec, Canada

Site Status

CHRU Brest - Hôpital de la Cavale Blanche

Brest, , France

Site Status

Centre Hospitalier Universitaire de Clermont-Ferrand - Gabriel-Montpied

Clermont-Ferrand, , France

Site Status

CHRU La Rochelle

La Rochelle, , France

Site Status

CHU de Montpellier - Hôpital Arnaud de Villeneuve

Montpellier, , France

Site Status

Nouvelles Cliniques Nantaises

Nantes, , France

Site Status

Centre hospitalier de la région d'Annecy

Pringy, , France

Site Status

Universitätsklinikum Aachen, AöR

Aachen, , Germany

Site Status

St. Vinzenz-Hospital Köln

Cologne, , Germany

Site Status

Universitätsklinikum Essen

Essen, , Germany

Site Status

Universitätsklinikum des Saarlandes

Homburg, , Germany

Site Status

Eberhard Karls Universität Tübingen - Universitätsklinikum Tübingen

Tübingen, , Germany

Site Status

Universitätsklinikum Ulm

Ulm, , Germany

Site Status

Magyar Honvédség Honvédkorház

Budapest, , Hungary

Site Status

Azienda Ospedaliera Ospedale Niguarda Cà Granda

Milan, , Italy

Site Status

Institut Jantung Negara - National Heart Institute

Kuala Lumpur, , Malaysia

Site Status

Maastricht Universitair Medisch Centrum

Maastricht, , Netherlands

Site Status

Maasstad Hospital Rotterdam

Rotterdam, , Netherlands

Site Status

Vychodoslovensky ustav srdcovych a cievnych chorob, a.s.

Košice, , Slovakia

Site Status

Samsung Medical Center

Seoul, , South Korea

Site Status

Hospital Universitario da Coruña

A Coruña, , Spain

Site Status

Hospital General Universitario Gregorio Maranon

Madrid, , Spain

Site Status

Hospital Universitario Son Espases

Palma de Mallorca, , Spain

Site Status

Complejo Hospitalario Universitario de Santiago de Compostela

Santiago de Compostela, , Spain

Site Status

University Hospitals of Birmingham NHS Foundation Trust - Queen Elizabeth Hospital

Birmingham, , United Kingdom

Site Status

Glenfield Hospital

Leicester, , United Kingdom

Site Status

Liverpool Heart and Chest Hospital NHS Foundation Trust

Liverpool, , United Kingdom

Site Status

Central Manchester University Hospitals NHS - Manchester Royal Infirmary

Manchester, , United Kingdom

Site Status

The James Cook University Hospital - South Tees Hospitals NHS

Middlesbrough, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Belgium Canada France Germany Hungary Italy Malaysia Netherlands Slovakia South Korea Spain United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MPP PAS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

MultiPoint Pacing Mapping Study
NCT02547207 TERMINATED
AdaptResponse Clinical Trial
NCT02205359 COMPLETED NA
MPP Programming Study
NCT01856725 COMPLETED NA